Get the Stockscreener App
29.76
1.54%
0.45
After Hours:
29.75
-0.01
-0.03%
Beta Bionics Inc stock is traded at $29.76, with a volume of 776.27K.
It is up +1.54% in the last 24 hours and up +5.68% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
See More
Previous Close:
$29.31
Open:
$29.46
24h Volume:
776.27K
Relative Volume:
0.99
Market Cap:
$1.31B
Revenue:
$78.02M
Net Income/Loss:
$-73.37M
P/E Ratio:
-22.55
EPS:
-1.32
Net Cash Flow:
$-62.06M
1W Performance:
+1.29%
1M Performance:
+5.68%
6M Performance:
+52.69%
1Y Performance:
+0.00%
1-Day Range:
$28.84
$30.50
1-Week Range:
$28.00
$30.50
52-Week Range:
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
29.76 | 1.29B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Resumed | Stifel | Buy |
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
Beta Bionics stock rating reiterated at Buy by Stifel - Investing.com South Africa
Beta Bionics: It Has Been An Interesting Year (NASDAQ:BBNX) - Seeking Alpha
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - The Manila Times
This Beta Bionics Insider Increased Their Holding By 130% Last Year - simplywall.st
Feider Stephen (Beta Bionics) sells $41,862 in shares By Investing.com - Investing.com Canada
Top Executives at Beta Bionics, Inc. Cash Out on Stock Sales - TipRanks
Mensinger, Beta Bionics CPO, sells $31k in BBNX stock By Investing.com - Investing.com Nigeria
Feider Stephen (Beta Bionics) sells $41,862 in shares - Investing.com
Beta Bionics Executives Sell Shares for Tax Obligations - TradingView
Officer Mensinger Files To Sell 1,063 Of Beta Bionics Inc [BBNX] - TradingView
With Beta Bionics Stock Sliding, Have You Assessed The Risk? - Trefis
Insider Sell Alert: Adam Lezack Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta Bionics Executives Sell Shares - TradingView
Beta Bionics (BBNX) Stock Analysis Report | Financials & Insights - Benzinga
Tech Watch: The Latest in Diabetes Tech News - Making Sense of Diabetes
BBNX Crosses Above Average Analyst Target - Nasdaq
Why Beta Bionics Inc. stock is a value investor pickJuly 2025 Snapshot & Free Safe Entry Trade Signal Reports - BỘ NỘI VỤ
Corporate – Shares – Settlement - Massachusetts Lawyers Weekly
Technical Analysis of Beta Bionics, Inc. (NASDAQ:BBNX) - TradingView
Why Beta Bionics Inc. stock is a must watch in 2025Trade Risk Summary & High Return Stock Watch Alerts - BỘ NỘI VỤ
What analysts say about Beta Bionics Inc stockMid Cap Growth Trends & Compound Your Gains With Quality Stocks - earlytimes.in
How currency fluctuations impact Beta Bionics Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Using economic indicators to assess Beta Bionics Inc. potentialMarket Volume Report & Stock Timing and Entry Methods - newser.com
How institutional buying supports Beta Bionics Inc. stockWeekly Market Summary & Real-Time Price Movement Reports - newser.com
Will Beta Bionics Inc. continue its uptrendStop Loss & Fast Gaining Stock Strategy Reports - newser.com
Regression analysis insights on Beta Bionics Inc. performanceWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
How supply chain issues affect Beta Bionics Inc. stockJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - newser.com
Beta Bionics Inc. stock chart pattern explainedJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Is Beta Bionics Inc. stock positioned for long term growthJuly 2025 Big Picture & Risk Controlled Daily Plans - newser.com
Will Beta Bionics Inc. price bounce be sustainableWeekly Risk Summary & AI Powered Market Trend Analysis - newser.com
Fourteen new option listings on November 12th - MSN
Beta Bionics (BBNX) Price Target Increased by 23.23% to 31.93 - Nasdaq
Visual trend scoring systems applied to Beta Bionics Inc.Stop Loss & Long-Term Growth Stock Strategies - newser.com
Is now a turning point for Beta Bionics Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):